Cargando…

Endothelial Ca(2+) Signaling, Angiogenesis and Vasculogenesis: Just What It Takes to Make a Blood Vessel

It has long been known that endothelial Ca(2+) signals drive angiogenesis by recruiting multiple Ca(2+)-sensitive decoders in response to pro-angiogenic cues, such as vascular endothelial growth factor, basic fibroblast growth factor, stromal derived factor-1α and angiopoietins. Recently, it was sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Moccia, Francesco, Negri, Sharon, Shekha, Mudhir, Faris, Pawan, Guerra, Germano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721072/
https://www.ncbi.nlm.nih.gov/pubmed/31416282
http://dx.doi.org/10.3390/ijms20163962
Descripción
Sumario:It has long been known that endothelial Ca(2+) signals drive angiogenesis by recruiting multiple Ca(2+)-sensitive decoders in response to pro-angiogenic cues, such as vascular endothelial growth factor, basic fibroblast growth factor, stromal derived factor-1α and angiopoietins. Recently, it was shown that intracellular Ca(2+) signaling also drives vasculogenesis by stimulation proliferation, tube formation and neovessel formation in endothelial progenitor cells. Herein, we survey how growth factors, chemokines and angiogenic modulators use endothelial Ca(2+) signaling to regulate angiogenesis and vasculogenesis. The endothelial Ca(2+) response to pro-angiogenic cues may adopt different waveforms, ranging from Ca(2+) transients or biphasic Ca(2+) signals to repetitive Ca(2+) oscillations, and is mainly driven by endogenous Ca(2+) release through inositol-1,4,5-trisphosphate receptors and by store-operated Ca(2+) entry through Orai1 channels. Lysosomal Ca(2+) release through nicotinic acid adenine dinucleotide phosphate-gated two-pore channels is, however, emerging as a crucial pro-angiogenic pathway, which sustains intracellular Ca(2+) mobilization. Understanding how endothelial Ca(2+) signaling regulates angiogenesis and vasculogenesis could shed light on alternative strategies to induce therapeutic angiogenesis or interfere with the aberrant vascularization featuring cancer and intraocular disorders.